The UK government is worried about a bid by an activist investor to shake up GlaxoSmithKline, and could make use of new powers to protect companies that are seen as vital to the nation’s interests.
Alongside AstraZenenca, GSK is one of UK’s two big pharma companies, employing 13,000 people in the country and investing around...